How does control of chronic disease affect implant assessment?｜證據鏈

Implant assessment cannot merely tick “yes” or “no” for chronic disease. Within the same diagnosis, recent control, comorbidities, medicines, wound-healing conditions and ability to maintain treatment can differ. Two limiters here are easy to skip: the review states that diabetes does negatively affect osseointegration, and that most studies focus on well-controlled diabetics and the use of prophylactic antibiotics — so the evidence base itself is weighted towards well-controlled patients and cannot be read as applying to all diabetic patients; the same review also records increased long-term bone and soft tissue complications. An umbrella review covering 8 systematic reviews found diabetes and osteoporosis to be the most studied systemic conditions, but data for many other diseases and medicines remain sparse and conclusions require confirmation. The practical question is not simply “can someone with chronic disease have an implant?” but whether the current condition is stable, which identifiable risks can be managed, and how surgical extent, timing and maintenance should be individualised. Diabetes evidence is particularly instructive: short-term implant survival may remain high, yet groups with higher glycated haemoglobin showed worsening trends in bleeding on probing and marginal bone change. Dentistry therefore needs current control information rather than promising success or failure from a diagnosis alone.